US FDA approves first mRNA flu shot from Moderna

The Food and Drug Administration (FDA) late Wednesday approved the nation's first mRNA flu vaccine, manufactured by drugmaker Moderna. The FDA has approved Moderna's flu vaccine for people aged 50 and older, marking the first approval of a messenger RNA-based vaccine for seasonal flu.